November 2019 - Page 42 of 159

NASDAQ Companies - November 19, 2019

NETGEAR® Announces Retirement of John McHugh; Names Vikram Mehta His Successor

SAN JOSE, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) — NETGEAR, Inc. (NASDAQ: NTGR), the industry’s leading provider of leading-edge networking […]

NASDAQ Companies - November 19, 2019

Akcea and Ionis Announce Closing of Licensing Agreement with Pfizer Inc. for Investigative Antisense Therapy AKCEA-ANGPTL3-L(Rx)

BOSTON and CARSLBAD, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis […]

NASDAQ Companies - November 19, 2019

NextCure Announces Closing of Public Offering

BELTSVILLE, Md., Nov. 19, 2019 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and […]

NASDAQ Companies - November 19, 2019

iRhythm Technologies Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q

SAN FRANCISCO, Nov. 19, 2019 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC) announced today that it received a standard […]

NASDAQ Companies - November 19, 2019

Middlesex Water Company Announces Proposed Public Offering of Common Stock

ISELIN, N.J., Nov. 19, 2019 (GLOBE NEWSWIRE) — Middlesex Water Company (“Middlesex” or the “Company”) (NASDAQ:MSEX), a provider of regulated […]

NASDAQ Companies - November 19, 2019

Organogenesis Holdings Inc. Announces Proposed Public Offering of Class A Common Stock

CANTON, Mass., Nov. 19, 2019 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on […]

NASDAQ Companies - November 19, 2019

Micron Technology to Report Fiscal First Quarter Results on December 18, 2019

BOISE, Idaho, Nov. 19, 2019 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) announced today that it will hold its […]

NASDAQ Companies - November 19, 2019

Checkpoint Therapeutics Announces Proposed Public Offering of Common Stock

NEW YORK, Nov. 19, 2019 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology […]